The Venture Codex Logo

The Venture Codex

Quark Venture

#2500-1075 West Georgia St., Vancouver, BC, V6G 3K3, Canada

Overview

Venture capital firm investing in innovative biotech and health sciences.

Founded

2015

Deals · 12mo

0

Links

WebsiteLinkedIn

Stage focus

Series B
Series C

Geographic focus

Canada
Israel
United States

Sector focus

—

Investment portfolio

24rounds
NAMEDATESIZE
Alpha9 Theranostics
Dec 2022Participated
$75 MSeries B
Koneksa Health
Feb 2022Participated
$45 MSeries C
Lyndra Therapeutics
Jun 2021Participated
$61 MSeries C
Volastra Therapeutics
Apr 2021Participated
$32 MSeed
Variantyx
Mar 2021Led
$20 MSeries C
CalciMedica
Mar 2021Led
$21 MSeries D
Eyevensys
Jan 2020Participated
$30 MSeries B
Raziel Therapeutics
Dec 2019Participated
$22 MSeries C
Pi Therapeutics
May 2019Participated
$20 MSeries B
Sitka Biopharma
Oct 2018Led
$2 MOther Equity
Canary Medical
May 2018Led
$10 MOther Equity
V-Wave
Apr 2018Participated
$70 MSeries C
Alpha9 Theranostics
Dec 2022Participated
$75 MSeries B
Koneksa Health
Feb 2022Participated
$45 MSeries C
Lyndra Therapeutics
Jun 2021Participated
$61 MSeries C
Volastra Therapeutics
Apr 2021Participated
$32 MSeed
Variantyx
Mar 2021Led
$20 MSeries C
CalciMedica
Mar 2021Led
$21 MSeries D
Eyevensys
Jan 2020Participated
$30 MSeries B
Raziel Therapeutics
Dec 2019Participated
$22 MSeries C
Pi Therapeutics
May 2019Participated
$20 MSeries B
Sitka Biopharma
Oct 2018Led
$2 MOther Equity
Canary Medical
May 2018Led
$10 MOther Equity
V-Wave
Apr 2018Participated
$70 MSeries C
24
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Quark Venture: 24 funding rounds are recorded in the selected participation categories.All available history.
Quark Venture: 24 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed01
Series A02
Series B26
Series C+24
Other Equity70

Monthly Deal Activity

Quark Venture: 24 deals are recorded across 121 months.All available history.
Quark Venture: 24 deals are recorded across 121 months. All available history
MonthDeals
Oct '162
Nov '160
Dec '161
Jan '172
Feb '170
Mar '170
Apr '171
May '170
Jun '171
Jul '171
Aug '170
Sep '170
Oct '172
Nov '170
Dec '171
Jan '180
Feb '181
Mar '180
Apr '181
May '181
Jun '180
Jul '180
Aug '180
Sep '180
Oct '181
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '191
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '190
Dec '191
Jan '201
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '212
Apr '211
May '210
Jun '211
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '221
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '221
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Quark Venture: Health & Life Sciences is the largest displayed sector by deal count (23 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Quark Venture: Health & Life Sciences is the largest displayed sector by deal count (23 deals). All available history
SectorDeals
Health & Life Sciences23
Data, Analytics & IT3
Space & Frontier Tech2
Networks, Cloud & Communication1
Hardware & Robotics1
Enterprise Software1
Manufacturing1
Cybersecurity & Privacy1
Consumer & Lifestyle1

Deal Size Distribution

Quark Venture: 24 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Quark Venture: 24 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M5
$5M-$10M1
$10M-$25M9
$25M-$50M6
$50M-$100M3
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Quark Venture: United States has the largest recorded deal count among the displayed regions (12 deals).All available history.

Top 4 of 4 regions; European countries are grouped as Europe.

Quark Venture: United States has the largest recorded deal count among the displayed regions (12 deals). All available history
RegionDeals
United States12
Canada6
Israel4
Europe2
Quark Venture: 20 co-investors are shown, with GF Securities sharing 9 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Quark Venture: 20 co-investors are shown, with GF Securities sharing 9 recorded deals. All available history
Co-investorShared deals
GF Securities9
Pontifax6
Polaris Partners4
BioStar Ventures2
Triventures2
20/20 HealthCare Partners1
4490 Ventures1
AIG Investments1
Aperture Venture Partners1
ARCH Venture Partners1
Arkin Bio Ventures1
BDC Capital1
BioScience Managers1
Boehringer Ingelheim1
Bpifrance1
BRM Group1
BVF Partners1
Caixa Capital Risc1
Catalio Capital Management1
Catalyst Fund1

Investment Strategy

Quark Venture: Led accounts for 46% and participating for 54% of round participation.All available history.
Quark Venture: Led accounts for 46% and participating for 54% of round participation. All available history
CategoryDeals (count)Share (%)
Led1146%
Participating1354%
Quark Venture: Single-lead accounts for 45% and co-led for 55% of lead dynamics.All available history.
Quark Venture: Single-lead accounts for 45% and co-led for 55% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead545%
Co-led655%

Team

Jesson Chen

Co-Founder, Chairman & Partner

Karimah Es Sabar

Chief Executive Officer & Partner

Neena Kadaba

Director, Science

Zafrira Avnur

Chief Scientific Officer